Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,388,569
+$702,728 QoQ
Shares Held
88,627
-0.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#699
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $116,130,341 across 15 Drug Manufacturers - General names. MRK ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,147 | $24,164,918 | |
| 2 | JNJ |
Johnson & Johnson
|
77,048 | $19,567,880 | |
| 3 | ABBV |
AbbVie Inc.
|
56,848 | $14,305,230 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
88,627 | $11,388,569 | |
| 5 | AZN |
Astrazeneca PLC
|
50,534 | $9,582,257 | |
| 6 | NVS |
Novartis AG
|
61,000 | $9,559,920 | |
| 7 | AMGN |
Amgen Inc
|
16,658 | $6,032,194 | |
| 8 | NVO |
Novo Nordisk A S
|
115,512 | $5,537,645 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,388,569 | 88,627 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,685,841 | 88,834 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,225,512 | 87,645 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,272,870 | 86,654 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,374,172 | 67,890 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,990,460 | 44,457 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,025,186 | 30,410 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,966,537 | 34,929 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,456,800 | 36,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,304,736 | 32,624 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,589,592 | 32,926 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,433,691 | 33,353 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,591,629 | 31,126 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,352,348 | 31,510 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,436,676 | 30,975 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,382,251 | 27,662 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,235,306 | 24,518 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,029,670 | 24,737 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,792,609 | 23,390 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,723,624 | 22,948 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,547,778 | 19,902 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,415,373 | 18,360 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,341,110 | 16,395 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,384,187 | 16,687 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,355,672 | 17,531 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,022,410 | 26,286 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||